Microsoft word - mark delahunty professional resume 2013.doc

3800 Galt Ocean Drive, Suite 606 • Ft. Lauderdale, FL 33308 • (281) 536-2971 • mdelahunty1@yahoo.com
H E A L T H C A R E I N D U S T R Y – E X E C U T I V E L E A D E R
* Multiple-Site Management * Full P&L Responsibility * Business and Strategic Planning * Transformational Leadership
* Business Development * Quality Outcomes * Clinical Research * C-Suite, Physician & Medical Personnel Partnerships * Process Improvement * Cost Management * Business Compliance * Team Building * Data Analysis * Customer Service P R O F E S S I O N A L W O R K E X P E R I E N C E NATIOWIDE LABORATORY SERVICES
Chief Executive Officer and Chairman of the Board, Ft. Lauderdale, Florida FRESENIUS MEDICAL CARE
Regional Vice President, Houston, Texas Successfully operated a $200 million net revenue business Grew portfolio to 38 outpatient dialysis clinics and 19 hospital inpatient contracts Transformed business to improve EBIT margin from 11% to 19% ($8 million) Increased quality score from 296 to 385 (HD) and from 303 to >400 (PD)
PARKINSON’S DISEASE AND MOVEMENT DISORDER CENTER
Executive Director of Scientific Affairs and Clinical Research, Boca Raton, Florida Researched and wrote grants to obtain federal and state funding for clinical research Developed company brand, marketing materials and website Raised working capital by facilitating various fund raising events throughout the local community Conducted applied statistical research on nationwide dataset of Parkinson’s Disease patients Determine statistical conclusions for abstract journal publications Developed and implemented patient outreach and rehabilitation programs
DAVITA
Regional Operations Director, Ft. Lauderdale, Florida Managed 25 outpatient dialysis facilities, 4 Joint Venture Partnerships and >450 employees Successfully managed a $50 million operating budget 8% realized growth in patient treatment numbers Improved EBITDA margin by 12% due to effective cost management ($6 million) Best clinical MBD score throughout the entire organization Increased annual acute business revenue ($1 million) GAMBRO HEALTHCARE
(2006-2008) Managing Director/UK Country Manager, Cambridge, England 8 outpatient dialysis facilities, >100 employees and gross revenue > 15 million GBP Provided overall leadership and strategic direction for the United Kingdom business operations Rebranded company locally with innovative competitive service offering and improved value proposition Optimized the request for proposal tendering process in partnership with the UK National Health Service 60% growth in new business contracts and 100% renewal of existing contracts Improved operating EBITDA margin by 25% (-10% to +15%) (2004-2006) Director of International Clinic Operations, Lund, Sweden Corporate position with $2.2B operating income and ~5,000 employees Developed and implemented key performance metrics and reporting tools Procurement of products and services for 170 dialysis clinics throughout 15 countries Successfully standardized company product portfolio to reduce supply cost ($500,000) Saved clinics in labor cost by implementing various scheduling techniques and process initiatives ($3 million) Standardized all country management operating structures (2003-2004) Regional Director, Columbia, Maryland Business leader for 6 outpatient dialysis facilities and 2 PD Programs Successfully turnaround a $12 million business operation Conducted clinical trials with Amgen, Genzyme, Nabi and Genentech Improved EBITDA margin by 9% due to effective cost management ($1 million) (2001-2003) Quality Manager/Biostatistician for Scientific Affairs and Clinical Research, Ft. Lauderdale, Florida Predicted patient outcomes and survival with bio-statistical analysis Conducted studies on drug efficacy, tolerability and optimal dosing levels Published >10 peer reviewed scientific abstracts in various nephrology journals Developed companywide quality management program, reports and performance scorecards Taught six sigma improvement methodologies nationwide Increased annual laboratory business revenue ($2 million)
NORTH BROWARD HOSPITAL DISTRICT
CBO Systems and Operations Consultant, Ft. Lauderdale, Florida Successfully managed all system aspects of healthcare revenue cycle Increased productivity: AP, AR, billing, legal, cash posting, customer service Developed reference databases to generate financial and operational reports Analyzed and disputed hospital claim rejections and denials by payers Negotiated new contracts and settlement agreements with insurance providers FLORIDA DEPARTMENT OF LAW ENFORCEMENT
Crime Intelligence Analyst – Economic Crime Squad, Miami, Florida Analyzed business accounting practices to reveal money laundering activities Analyzed business banking transactions to support narcotic trafficking trends Investigated hospital systems for medical billing fraud activities Linked all suspects to dismantling nationwide criminal organizations Conducted interrogation interviews on arrested suspects and court testified
UNIVERSITY OF WISCONSIN-PARKSIDE
Mathematics and Applied Statistics Instructor, Kenosha, Wisconsin Provided tutoring services and examination study guides for >3,000 university students Demonstrated statistical software for performing basic demographic, regression and correlation analysis Created a healthcare predictive modelling program for patient survival Simplified textbook applied statistics, college algebra and calculus formulas and questions E D U C A T I O N A N D S P E C I A L I Z E D T R A I N I N G
DOCTORATE OF HEALTH ADMINISTRATION
Central Michigan University, Mount Pleasant, Michigan CERTIFIED SIX SIGMA BLACK BELT
American Society for Quality, Scottsdale, Arizona MASTERS OF PUBLIC ADMINISTRATION
Florida Atlantic University, Boca Raton, Florida BACHELORS OF SOCIOLOGY
University of Wisconsin-Parkside, Kenosha, Wisconsin NATIONAL DIPLOMA IN BUSINESS AND FINANCE
S C I E N T I F I C P U B L I C A T I O N S
Pennel, P, Leclercq, B, Delahunty, MI, Walters, BAJ. The Utility of Non-HDL in Managing Dyslipidemia of Stage 5 Chronic
Kidney Disease. Clin Nephrol., 66:1-12, 2006.
Walters, BAJ, Delahunty, MI, Bosch, JP. Eleven Outcome Performance Measures for a Hemodialysis Quality Management Program Correlate with Mortality. JASN 14: 870A, (abstr), 2003. Walters, BAJ, Delahunty, MI, Pennell, P. Vascular Access Type Influences Variation in Mean Delivered Dialysis Dose Leading to Under-dialysis. JASN 14:808A, (abstr), 2003. Delahunty, MI, Walters, BAJ, Pennell, P. Reduction in the Variation of Delivered Dialysis Dose (spKt/V) Using Six Sigma Quality Improvement Methodology is Associated with a Reduction in Exposure to Under-dialysis. JASN 14: 684A, (abstr), 2003. Pennell, P, Delahunty, MI, Walters, BAJ. Lipid Profiles in Stage 5 Chronic Kidney Disease Patients: Implications for Therapy. JASN 14:197A, (abstr), 2003. Walters, BAJ, Delahunty, M, Nabut, JL, Pennell, P, Bosch, JP. Reduction in Cardiac Mortality in Hemodialysis Patients on Sevelamer Hydrochloride Compared with Phosphate Binders Containing Calcium. JASN 13: 596A, (abstr), 2002. Pennell, P, Delahunty, M, Walters, BAJ. Arthrogenic Lipid Profile in Dialysis Patients: The Need to Target Low Density Lipoprotein. JASN 13: 594A, (abstr), 2002. Walters, BAJ, Delahunty, M, Rojas, C, Pennell, P, Bosch, JP. Control of Serum Phosphate Level by Sevelemer Hydrochloride May Occur at the Expense of Lowering Serum Bicarbonate in Hemodialysis Patients. JASN 13: 586A, (abstr), 2002. Burke, H, Ranich, TP, Delahunty, MI, Hoang, AD, Velasquez, MT, Kimmel, PL, Walters, BA, Bosch, JP. Racial Survival Advantage and Cardiovascular Medications in Hemodialysis Patients. JASN 2002; 13: 438A, (abstr), 2002. Ranich, TP, Delahunty, MI, Burke, H, Hoang, AD, Velasquez, MT, Kimmel, PL, Walters, BA, Bosch, JP. Angiotensin Converting Enzyme Inhibitor Use in Prevalent Hemodialysis Patients and Relation to Survival JASN 13:440A, (abstr), 2002. I was a Welsh international chess and rugby player before the age of eighteen. My rugby career ended after being in a comma for 3 weeks due to a major car accident that was almost fatal. I had the opportunity to become a college student in America and created a new purpose in life with all my competitive spirit being redirected into academics and making the decision to relocate abroad. When working with the Florida Department of Law Enforcement, I was assigned to the Federal Bureau of Investigation and successfully dismantled numerous organized crimes involving money laundering, narcotics, and medical fraud schemes throughout the State of Florida. This involved using various analytical and investigation techniques for which I was specifically trained by government special agents. I decided to change my career after being followed home one too many times and my wife expressing legitimate family safety concerns. • For almost 20 years of my career, I have been mentored by some of the finest medical and business professionals who have given me the opportunity and ability to not only aspire to senior executive levels within the healthcare industry, but also travel the world and gain an understanding of the various cultures, healthcare systems and quality standards of care being delivered to patients on a global level. I have been successful in the development and implementation of a worldwide quality management program that has significantly reduced dialysis patient hospitalizations and mortality rates. I have often created company and shareholder value by building strong physician relationships and driving millions of dollars to the bottom line by increasing top line growth and successfully managing costs without compromising quality throughout my entire healthcare industry career. P R O F E S S I O N A L R E F E R E N C E S Excellent references available upon request

Source: http://www.dialysisconsultant.org/professional-resume.pdf